Catalyst Wire Dossier Catalyst Wire Dossier

Sarecycline (Seysara)

sarecycline · Almirall, S.A.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Sarecycline (Seysara), covering 2018-05-04 to 2018-05-04. Get the full timeline:

Most recent: Clinical Trial Update: A Multi-Center Open-Label Evaluation of the Safety of Sarecycline Tablets in the Treatment of Acne Vulgaris [Phase 3]

See pricing